AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $777M |
| Operating income | −$186M |
| Net income | −$192M |
| EPS | −$3.75 |
| Free cash flow | −$72M |
Axsome Therapeutics, Inc.
$179.25−2.82 (−1.55%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Revenue | $777M |
| Operating income | −$186M |
| Net income | −$192M |
| EPS | −$3.75 |
| Free cash flow | −$72M |